SEC Form D · filed April 16, 2024
Outlook Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Yezan H. Haddadin · Iselin, NJDirectorKurt J. Hilzinger · Iselin, NJDirectorAndong G. Huang · Iselin, NJDirectorLawrence A. Kenyon · Iselin, NJExec · DirectorC. R. Trenary · Iselin, NJExec · DirectorJulian G. Gangolli · Iselin, NJDirectorRandy H. Thurman · Iselin, NJDirectorJeff R. Evanson · Iselin, NJExecGerd G. Auffarth · Iselin, NJDirectorJulia A. Haller · Iselin, NJDirectorFaisal G. Sukhtian · Iselin, NJDirectorMark H. Barineau · Houston, TXDirectorRajesh Sharma · Saint-Laurent, Quebec, CanadaDirectorJames Bracken · Schaumburg, ILDirectorLuke Terrell · Fayetteville, ARDirectorM. W. Macey, Jr · Greenwich, CTDirectorMelvyn Reznick · Reno, NVExec · DirectorJeff R. Evanson · Iselin, NJExecAlan Pierrot · Fresno, CADirectorMichael A. Barr · Greenwich, CTDirectorGilles Lamarre · Ottawa, Ontario, CanadaExec · DirectorJoseph J. Gault · Greenwich, CTDirectorAvraham D. Dreyfuss · New York, NYDirectorMichael A. Scott · San Francisco, CADirectorAubrey Rankin · AUSTIN, TXDirectorDon Maniccia · AUSTIN, TXDirectorJared Hoffman · New York, NYDirectorNikolaos Perros · New York, NYDirectorLu Cai · New York, NYExec · DirectorXiao Jian Wang · New York, NYDirectorYun Zhang · New York, NYExec · DirectorLei Zhang · New York, NYDirectorMartin Steyn · Grand Cayman, Cayman IslandsExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗